Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127192181 | 12719218 | 1 | I | 20121116 | 20141201 | 20160907 | 20160907 | EXP | JP-ROCHE-1824034 | ROCHE | 22.00 | YR | M | Y | 76.00000 | KG | 20160907 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127192181 | 12719218 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous drip | 125085 | 380 | MG | SOLUTION FOR INFUSION | QD | |||||||
| 127192181 | 12719218 | 2 | C | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Unknown | DOSAGE IS UNCERTAIN. | 0 | ||||||||||
| 127192181 | 12719218 | 3 | C | VITAMIN E | .ALPHA.-TOCOPHEROL | 1 | Oral | DOSAGE IS UNCERTAIN. | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127192181 | 12719218 | 1 | Radiation necrosis |
| 127192181 | 12719218 | 2 | Brain neoplasm |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127192181 | 12719218 | DE |
| 127192181 | 12719218 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127192181 | 12719218 | Haemorrhage intracranial | |
| 127192181 | 12719218 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127192181 | 12719218 | 1 | 20121109 | 20121109 | 0 |